











| CONFERENCE PROGRAM |
| 4th iCRO is co-organized by HAZU and University of Zagreb School of Medicine (Project BIO-CHIP) in cooperation with the COS Section for Translational Medicine - Translating basic science into clinical practice |
| Chairmen: Christopher H. Evans, USA and Ivan Martin, Switzerland |
| 08:30 - 09:20 - Free papers |
|
09:30 - 09:35 - Introduction Marko Pećina, Croatia & Alan Ivković, Croatia |
|
09:35 - 09:55 - Translational musculoskeletal approaches in the Austrian Cluster for Tissue Regeneration Heinz Redl, Austria |
|
09:55 - 10:15 - Getting arthritis gene therapy into clinic Christopher H. Evans, USA |
|
10:15 - 10:35 - Nose2Knee Ivan Martin, Switzerland |
|
10:35 - 10:55 - Rebuilding the knee, hip and ankle with cells rather than metals James Richardson, United Kingdom |
|
10:55 - 11:15 - PRP: why intra-articular? From preclinical rational to evidence for its use in the clinical practice Giuseppe Filardo, Italy |
| 11:15 - 11:20 - Discussion |
| 4th iCRO is co-organized by HAZU and University of Zagreb School of Medicine (Project BIO-CHIP) in cooperation with the COS Section for Translational Medicine - Translating basic science into clinical practice |
| Chairmen: Christopher H. Evans, USA and Ivan Martin, Switzerland |
| 08:30 - 09:20 - Free papers |
|
09:30 - 09:35 - Introduction Marko Pećina, Croatia & Alan Ivković, Croatia |
|
09:35 - 09:55 - Translational musculoskeletal approaches in the Austrian Cluster for Tissue Regeneration Heinz Redl, Austria |
|
09:55 - 10:15 - Getting arthritis gene therapy into clinic Christopher H. Evans, USA |
|
10:15 - 10:35 - Nose2Knee Ivan Martin, Switzerland |
|
10:35 - 10:55 - Rebuilding the knee, hip and ankle with cells rather than metals James Richardson, United Kingdom |
|
10:55 - 11:15 - PRP: why intra-articular? From preclinical rational to evidence for its use in the clinical practice Giuseppe Filardo, Italy |
| 11:15 - 11:20 - Discussion |
| Past iCRO conferences |
| iCRO is organised by: |







| Funding for this conference has been received from the European Union’s Seventh Programme for research, technological development and demonstration under grant agreement No. 278807, BIO-COMET and from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 681103, BIO-CHIP. |